Doug Fulling, MA, and Andrew Cournoyer of Precision AQ discussed what payers can contribute to discussions around drug ...
Results from a single-center, observational, prospective study suggested that inflammatory markers could predict disease ...
Artificial intelligence (AI) models have potential to help clinicians assess risk in patients with hepatocellular carcinoma ...
The FDA has approved deuruxolitinib, an oral medication developed by Sun Pharma, as the first-line treatment for adults with ...
These 48-week data from ARTISTRY-1 build on 24-week results previously presented and show enduring efficacy of bictegravir ...
The authors of the new meta-analysis aimed to provide an update on the association between ankylosing spondylitis and cancer incidence.
The ending of the 2023 film “Barbie,” where she sees a gynecologist, has increased online search interest in gynecology; yesterday marked 34 years of the Americans With Disabilities Act (ADA); Texas ...
Legal and policy experts on a KFF webinar explained how the Supreme Court’s recent decision to overturn the Chevron precedent ...
A federal appeals court ruled yesterday that a group of Republican-led states do not have legal standing to impose ...
Health care inequity is costing the United States billions of dollars without providing quality outcomes for patients with ...
This new analysis examined the investigational chimeric antigen receptor (CAR) T-cell therapy GC012F among patients with ...
The phase 3, international, open-label, single-group XTEND-Kids study concluded that children with severe hemophilia A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results